Experts Emphasize Therapy Options, Expanded Mutation Testing in mCRC
November 18th 2014
Confusion persists about the best choice of frontline therapy for patients with metastatic colorectal cancer (mCRC) after a landmark clinical trial that was conceived a decade ago to answer that question concluded without a superiority finding